Evidence map›Paper›PMID 41143156›Full record

ReviewJBMR plus2025

Osteitis fibrosa cystica recovery following parathyroidectomy for primary hyperparathyroidism: a case series and review of literature.

Yehudit Eden-Friedman, Amna Jabarin, Gadi Shlomai, Reut Halperin, Amit Tirosh, Yair Schwartz, Iris Vered, Yael Levy-Shraga, Iris Eshed, Liana Tripto-Shkolnik

Abstract readReview
In one paragraph

Review in JBMR plus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yehudit Eden-FriedmanDivision of Endocrinology, Diabetes and Metabolism, Chaim Sheba Medical Center, Tel-Hashomer, Ramat Gan, 5266202, Israel.ORCID https://orcid.org/0000-0002-0806-1938
Amna JabarinDivision of Endocrinology, Diabetes and Metabolism, Chaim Sheba Medical Center, Tel-Hashomer, Ramat Gan, 5266202, Israel.
Gadi ShlomaiDivision of Endocrinology, Diabetes and Metabolism, Chaim Sheba Medical Center, Tel-Hashomer, Ramat Gan, 5266202, Israel.
Reut HalperinDivision of Endocrinology, Diabetes and Metabolism, Chaim Sheba Medical Center, Tel-Hashomer, Ramat Gan, 5266202, Israel.
Amit TiroshDivision of Endocrinology, Diabetes and Metabolism, Chaim Sheba Medical Center, Tel-Hashomer, Ramat Gan, 5266202, Israel.ORCID https://orcid.org/0000-0003-3794-9634
Yair SchwartzDivision of Endocrinology, Diabetes and Metabolism, Chaim Sheba Medical Center, Tel-Hashomer, Ramat Gan, 5266202, Israel.
Iris VeredDivision of Endocrinology, Diabetes and Metabolism, Chaim Sheba Medical Center, Tel-Hashomer, Ramat Gan, 5266202, Israel.
Yael Levy-ShragaGray Faculty of Medical and Health Sciences, internal medicine department, Tel Aviv University, 69978, Israel.
Iris EshedGray Faculty of Medical and Health Sciences, internal medicine department, Tel Aviv University, 69978, Israel.
Liana Tripto-ShkolnikDivision of Endocrinology, Diabetes and Metabolism, Chaim Sheba Medical Center, Tel-Hashomer, Ramat Gan, 5266202, Israel.ORCID https://orcid.org/0000-0002-1892-7264

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteitis fibrosa cystica (OFC) is an extreme manifestation of accelerated bone resorption in primary hyperparathyroidism (PHPT), rarely encountered nowadays. Bone mineral density gain following parathyroidectomy (PTx) is well documented, while little is known regarding the timeline of lytic lesions remineralization and recovery. We present three patients with OFC, surgically treated for PHPT, with clinical, biochemical, and advanced radiological (CT or MRI) post-PTx follow-up. Additionally, we review published OFC case reports that include serial imaging of bony lesions following PTx. All patients received calcium, magnesium and alphacalcidiol supplementation post-PTx with serum calcium, PTH, and alkaline phosphatase gradually normalizing. Patients 1 and 2 exhibited an impressive remineralization of pelvic lytic lesions within 6 and 12 mo following PTx, respectively. Patient 3 showed partial remineralization of C4-C5 vertebrae at 6 mo, with continued improvement at 18 mo post-PTx. Both Patients 1 and 3 required salvage orthopedic intervention. We summarize reports of 54 patients with PHPT and OFC, assessed for lytic lesion recovery after PTx using various imaging modalities. Most lesions showed partial remineralization within 6-12 mo. Near full and complete remineralization was evident in 38 (70.3%) of the patients on the last imaging follow-up. Substantial remineralization of lytic lesions in OFC can be observed within months of PTx, even in large or symptomatic lesions. This early skeletal recovery may obviate the need for orthopedic intervention in selected patients and supports a conservative management approach when lesion location permits.

Indexed as

hypercalcemialytic lesionsosteitis fibrosa cysticaparathyroidectomyprimary hyperparathyroidismremineralization

Identifiers

PMID41143156
PMCPMC12548736

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.